JP2003506093A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003506093A5 JP2003506093A5 JP2001515842A JP2001515842A JP2003506093A5 JP 2003506093 A5 JP2003506093 A5 JP 2003506093A5 JP 2001515842 A JP2001515842 A JP 2001515842A JP 2001515842 A JP2001515842 A JP 2001515842A JP 2003506093 A5 JP2003506093 A5 JP 2003506093A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- csfv
- amino acid
- fusion protein
- pro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 description 18
- 102000004196 processed proteins & peptides Human genes 0.000 description 18
- 108090000765 processed proteins & peptides Proteins 0.000 description 18
- 238000000034 method Methods 0.000 description 7
- 150000001413 amino acids Chemical group 0.000 description 6
- 230000000468 autoproteolytic effect Effects 0.000 description 6
- LXWYCLOUQZZDBD-LIYNQYRNSA-N csfv Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LXWYCLOUQZZDBD-LIYNQYRNSA-N 0.000 description 6
- 108020001507 fusion proteins Proteins 0.000 description 6
- 102000037865 fusion proteins Human genes 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 4
- 241000710778 Pestivirus Species 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 210000003000 inclusion body Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- PPBOKXIGFIBOGK-BDTUAEFFSA-N bvdv Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C1=CN=CN1 PPBOKXIGFIBOGK-BDTUAEFFSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 108010043393 protease N Proteins 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT1367/99 | 1999-08-09 | ||
| AT136799 | 1999-08-09 | ||
| PCT/EP2000/007643 WO2001011057A1 (en) | 1999-08-09 | 2000-08-07 | Production of proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003506093A JP2003506093A (ja) | 2003-02-18 |
| JP2003506093A5 true JP2003506093A5 (https=) | 2007-09-27 |
| JP4820512B2 JP4820512B2 (ja) | 2011-11-24 |
Family
ID=3512357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001515842A Expired - Lifetime JP4820512B2 (ja) | 1999-08-09 | 2000-08-07 | タンパク質の製造 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6936455B1 (https=) |
| EP (1) | EP1200604B1 (https=) |
| JP (1) | JP4820512B2 (https=) |
| KR (1) | KR20020026366A (https=) |
| CN (1) | CN1230543C (https=) |
| AT (1) | ATE335826T1 (https=) |
| AU (1) | AU775662B2 (https=) |
| CA (1) | CA2379571C (https=) |
| CZ (1) | CZ302366B6 (https=) |
| DE (1) | DE60029968T2 (https=) |
| ES (1) | ES2269173T3 (https=) |
| HK (1) | HK1047128B (https=) |
| HU (1) | HU230231B1 (https=) |
| IL (1) | IL147456A0 (https=) |
| MX (1) | MXPA02001424A (https=) |
| NO (1) | NO328339B1 (https=) |
| NZ (1) | NZ516869A (https=) |
| PL (1) | PL200225B1 (https=) |
| SK (1) | SK287488B6 (https=) |
| TR (1) | TR200200253T2 (https=) |
| WO (1) | WO2001011057A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200200048T2 (tr) * | 1999-08-09 | 2002-04-22 | Biochemie Gesellschaft M.B.H. | Otoproteolitik klevaj vasıtasıyla proteinlerin üretimi. |
| ES2453048T3 (es) | 2004-03-30 | 2014-04-03 | Relypsa, Inc. | Polímeros de unión de ión y usos de los mismos |
| PL1874825T3 (pl) * | 2005-04-26 | 2011-04-29 | Boehringer Ingelheim Rcv Gmbh | Ligandy powinowactwa |
| AU2011253661B2 (en) * | 2005-04-26 | 2013-06-13 | Boehringer Ingelheim Rcv Gmbh & Co Kg | Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| GB0508434D0 (en) * | 2005-04-26 | 2005-06-01 | Sandoz Ag | Organic compounds |
| GB0508435D0 (en) * | 2005-04-26 | 2005-06-01 | Sandoz Ag | Organic compounds |
| CN103069000A (zh) | 2010-08-31 | 2013-04-24 | 天野酶株式会社 | 使用了酶的蛋壳膜的溶解方法 |
| EP2684951A1 (en) | 2012-07-13 | 2014-01-15 | Sandoz Ag | Method for producing a recombinant protein of interest |
| EP2746390A1 (en) * | 2012-12-19 | 2014-06-25 | Sandoz Ag | Method for producing a recombinant protein of interest |
| EP2746391A1 (en) | 2012-12-19 | 2014-06-25 | Sandoz Ag | Method for producing a recombinant protein of interest |
| UY35874A (es) | 2013-12-12 | 2015-07-31 | Novartis Ag | Un proceso para la preparación de una composición de proteínas pegiladas |
| RU2619217C1 (ru) * | 2015-12-04 | 2017-05-12 | Федеральное государственное бюджетное учреждение "Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов" (ФГБУ "ГосНИИгенетика") | Температурочувствительный мутантный интеин для нерастворимой экспрессии предшественника целевого белка |
| CN114539425B (zh) * | 2022-02-25 | 2023-04-28 | 湖南中晟全肽生化有限公司 | 一种提高线性多肽生物表达的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743679A (en) | 1986-02-24 | 1988-05-10 | Creative Biomolecules, Inc. | Process for producing human epidermal growth factor and analogs thereof |
| EP0321973B1 (de) * | 1987-12-23 | 1993-11-03 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Expression der viral kodierten Protease P2A des HRV2 |
| TW505697B (en) * | 1997-04-25 | 2002-10-11 | Sembiosys Genetics Inc | Method for cleavage of fusion proteins |
| DE59812768D1 (de) | 1997-08-22 | 2005-06-09 | Roche Diagnostics Gmbh | Autokatalytisch aktivierbare zymogene vorstufen von proteasen und deren verwendung |
| WO1999010483A2 (de) | 1997-08-22 | 1999-03-04 | Roche Diagnostics Gmbh | Autokatalytisch aktivierbare vorstufen von proteasen und deren verwendung |
-
2000
- 2000-08-07 PL PL353101A patent/PL200225B1/pl unknown
- 2000-08-07 CA CA2379571A patent/CA2379571C/en not_active Expired - Lifetime
- 2000-08-07 JP JP2001515842A patent/JP4820512B2/ja not_active Expired - Lifetime
- 2000-08-07 MX MXPA02001424A patent/MXPA02001424A/es unknown
- 2000-08-07 NZ NZ516869A patent/NZ516869A/en not_active IP Right Cessation
- 2000-08-07 AT AT00958389T patent/ATE335826T1/de active
- 2000-08-07 HK HK02107014.5A patent/HK1047128B/en not_active IP Right Cessation
- 2000-08-07 HU HU0202519A patent/HU230231B1/hu unknown
- 2000-08-07 CZ CZ20020481A patent/CZ302366B6/cs not_active IP Right Cessation
- 2000-08-07 KR KR1020027001666A patent/KR20020026366A/ko not_active Ceased
- 2000-08-07 SK SK185-2002A patent/SK287488B6/sk not_active IP Right Cessation
- 2000-08-07 CN CNB008114595A patent/CN1230543C/zh not_active Expired - Lifetime
- 2000-08-07 WO PCT/EP2000/007643 patent/WO2001011057A1/en not_active Ceased
- 2000-08-07 TR TR2002/00253T patent/TR200200253T2/xx unknown
- 2000-08-07 US US10/048,882 patent/US6936455B1/en not_active Expired - Lifetime
- 2000-08-07 EP EP00958389A patent/EP1200604B1/en not_active Expired - Lifetime
- 2000-08-07 AU AU69933/00A patent/AU775662B2/en not_active Expired
- 2000-08-07 ES ES00958389T patent/ES2269173T3/es not_active Expired - Lifetime
- 2000-08-07 IL IL14745600A patent/IL147456A0/xx unknown
- 2000-08-07 DE DE60029968T patent/DE60029968T2/de not_active Expired - Lifetime
-
2002
- 2002-02-08 NO NO20020633A patent/NO328339B1/no not_active IP Right Cessation
-
2005
- 2005-04-05 US US11/099,302 patent/US20050186564A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2237296C (en) | Process for the preparation of peptides by way of streptavidin fusion proteins | |
| US8298789B2 (en) | Orthogonal process for purification of recombinant human parathyroid hormone (rhPTH) (1-34) | |
| US6207420B1 (en) | Fusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in Escherichia coli | |
| Sachdev et al. | Order of Fusions between Bacterial and Mammalian Proteins Can Determine Solubility inEscherichia coli | |
| JP5909172B2 (ja) | 融合タンパク質の自己タンパク質分解切断による組換えタンパク質の産生 | |
| US9006395B2 (en) | Recombinant toxin fragments | |
| US7897158B2 (en) | Recombinant toxin fragments | |
| US5707826A (en) | Enzymatic method for modification of recombinant polypeptides | |
| JP2003506093A5 (https=) | ||
| CA2443365A1 (en) | Methods for the recombinant production of antifusogenic peptides | |
| JPWO1999038984A1 (ja) | 補助ペプチドを用いたペプチドの製造方法 | |
| Maeda et al. | Expression of cDNA for batroxobin, a thrombin-like snake venom enzyme | |
| CA2379571A1 (en) | Process for the production of a heterologous peptide by autoproteolytic cleavage in vitro | |
| CN102282260A (zh) | 用于制备人重组胰岛素的方法 | |
| EP0422049A4 (en) | Vector for secretion of proteins directly into periplasm or culture medium | |
| EP1597369B1 (en) | Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions | |
| JP2549504B2 (ja) | Dna塩基配列、ポリペプチド分泌発現ベクター及び形質転換微生物 | |
| JP2005527632A (ja) | ポリペプチド切断方法 | |
| Fang et al. | Expression of recombinant Chinese bovine enterokinase catalytic subunit in P. pastoris and its purification and characterization | |
| JPH1175879A (ja) | プロテインジスルフィドイソメラーゼを含有する融合タンパク質をコードするdna | |
| US8956848B2 (en) | UBP1 protease mutant, and its coding sequence, their application and methods of production | |
| JPH02100685A (ja) | ポリペプチド分泌発現ベクター,該ベクターで形質転換した微生物及び該微生物によるポリペプチドの製造 | |
| JP2002533072A (ja) | β−リポトロピンおよび他のペプチドの組換え合成 | |
| JP2538200B2 (ja) | ポリペプチド分泌発現ベクタ―及び形質転換微生物 | |
| JPH01181796A (ja) | 組換えdna法を用いたポリペプチドの製造法 |